bimatoprost
FDA Approved
Description
Bimatoprost is a prostaglandin analog primarily used for glaucoma treatment and eyelash hypotrichosis. It has been used off-label for managing eyelash and eyebrow abnormalities in patients with hypertrichosis conditions. The medication promotes hair growth and can help normalize eyelash appearance in certain genetic conditions.
Indications & Therapeutic Use
hypotrichosis of eyelashes, glaucoma, ocular hypertension
Linked Diseases:
Global Availability (6 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
bimatoprost
| Generic Name | bimatoprost |
| Brands | 1 brand available |
| Active Ingredient | bimatoprost |
| Drug Class | hypotrichosis of eyelashes |
| Manufacturer | Allergan |
| Dosage Forms | ophthalmic solution 0.03%; topical solution 0.03% |
| Medical Code | S01EE03 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 14 days |
| Reg. Status | FDA Approved |
| Countries | 6 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations7 Validated Nodes